Device Trial Radar · NCT04744935
Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma
Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
29
Actual
Start
Jan 13, 2021
Primary completion
May 20, 2025
Study completion May 20, 2025
Sponsor
- Lead sponsor
- Christopher ZacharyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 9, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Optical coherence tomography guided laser treatment of basal cell carcinoma
Conditions
- Basal Cell Carcinoma
- Superficial Basal Cell Carcinoma
- Nodular Basal Cell Carcinoma
Interventions
1064 nm long-pulse Nd:YAG laserDevice
BCC lesion will be treated with long-pulse 1064 laser, with surface temperature monitored by infrared camera.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Complete Histological Clearance of BCC LesionTime frame: 1 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
UCI Health Dermatology Clinic
Irvine, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.